Danaher (DHR) DIvidends Date & History

Key Takeaways

• Danaher Corporation maintains a low dividend yield of approximately 0.83% with an annual payout of $1.60 per share.
• The company pays dividends quarterly and has demonstrated consistent increases over recent years.
• Payout ratio remains conservative at around 25%, supported by strong earnings and free cash flow.
• Danaher qualifies as a dividend growth stock rather than a high-yield income play.
• Dividend sustainability appears solid given low debt levels and robust financial metrics in the life sciences sector.
• Relative to industry peers, the yield is modest but growth trajectory stands out positively.

Dividend Overview

Danaher Corporation operates as a global leader in life sciences and diagnostics. The company follows a quarterly dividend schedule, with the most recent quarterly payment set at $0.40 per share. This translates to an annualized dividend of $1.60 and a current yield near 0.83%. Danaher is best characterized as a dividend growth stock, emphasizing steady increases over high current income. The policy reflects a balanced approach that prioritizes reinvestment in growth opportunities while returning capital to shareholders through rising distributions.

Dividend History and Growth

Danaher has maintained consistent quarterly payments for decades. Recent history shows meaningful growth, including an increase from $0.27 to $0.32 per share in early 2025 and a further rise to $0.40 announced in 2026. Annualized growth rates have averaged between 9% and 20% across various multi-year periods. The company exhibits a multi-year streak of dividend increases, positioning it as a reliable compounder for long-term holders focused on rising income streams.

Dividend Sustainability and Payout Ratio

The payout ratio stands at approximately 25%, indicating ample coverage by earnings. Free cash flow generation remains strong, providing additional headroom for dividend payments. Danaher maintains a conservative balance sheet with manageable debt levels relative to its cash-generating businesses. These factors collectively support ongoing dividend sustainability without straining core operations or limiting strategic investments.

Dividend Compared to Industry Peers

In the healthcare equipment and life sciences sector, peer companies such as Thermo Fisher Scientific and Abbott Laboratories also feature modest yields typically below 2%. Danaher’s yield aligns closely with this group average while its dividend growth rate has often exceeded sector norms in recent periods. This profile makes the stock competitive on growth but less attractive for investors seeking immediate high income.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to refine your search for dividend opportunities.

Is This Stock Attractive for Dividend Investors?

Danaher appeals primarily to dividend growth investors and long-term holders who value consistent increases over elevated current yields. The low payout ratio and strong cash flow profile suit conservative investors seeking stability in the healthcare sector. Income-focused investors may find the modest yield less compelling compared with higher-yielding alternatives elsewhere. Overall, the stock suits portfolios emphasizing capital appreciation alongside gradual dividend expansion rather than immediate high income.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations